Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Total Current Liabilities (2016 - 2025)

Cellectis (CLLS) has 8 years of Total Current Liabilities data on record, last reported at $48.1 million in Q4 2022.

  • For Q4 2022, Total Current Liabilities fell 2.47% year-over-year to $48.1 million; the TTM value through Dec 2022 reached $48.1 million, down 2.47%, while the annual FY2022 figure was $48.1 million, 2.47% down from the prior year.
  • Total Current Liabilities reached $48.1 million in Q4 2022 per CLLS's latest filing, down from $49.3 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $52.0 million in Q4 2020 and bottomed at $46.9 million in Q4 2018.
  • Average Total Current Liabilities over 4 years is $49.1 million, with a median of $48.7 million recorded in 2021.
  • Peak YoY movement for Total Current Liabilities: grew 3.12% in 2018, then dropped 5.13% in 2021.
  • A 4-year view of Total Current Liabilities shows it stood at $46.9 million in 2018, then increased by 10.98% to $52.0 million in 2020, then dropped by 5.13% to $49.3 million in 2021, then dropped by 2.47% to $48.1 million in 2022.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $48.1 million in Q4 2022, $49.3 million in Q4 2021, and $52.0 million in Q4 2020.